Stabilised GHRH analogue
Tesamorelin
GHRH analogue used as a labelled therapy for HIV-associated lipodystrophy in some markets, reducing visceral adipose tissue via GH/IGF-1.
Primary Mechanism of Action
Clinical / Scientific
Tesamorelin is a trans-3-hexenoic acid-modified GHRH analogue with improved stability. GHRHR agonism raises GH and IGF-1, shifting lipid handling and reducing visceral fat in labelled HIV lipodystrophy use.
Pathway Targets
GHRH receptor
Scientific explanation
GH-axis stimulation.
GH / IGF-1 axis
Scientific explanation
Downstream metabolic effects on visceral adipose tissue.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Receptor to physiology
Target to downstream effect: GHRH receptor → GH / IGF-1 axis
Mechanistically Relevant Repurposed & Adjunctive Applications
HIV-associated lipodystrophy (labelled markets)
EstablishedMechanistic rationale
Approved in some jurisdictions for excess abdominal fat in HIV lipodystrophy. Catalog vials are not automatically that licensed product.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| GHRHR | Agonism | GH-mediated visceral fat reduction in labelled use | Established mechanism |
Mechanistic Interaction Considerations
IGF-1 elevation, glucose intolerance, and oedema follow GH biology. Not for unmonitored stacking with other GH secretagogues.
In Plain Language
Tesamorelin is a sturdy GHRH copy that raises growth hormone. In some countries it is a real medicine for a specific HIV-related fat-distribution problem.
Compounds Sharing Pathways
Other library compounds whose structured pathway data overlap this ingredient. Shared pathways are not combination recommendations.
GHRH receptor
GH / IGF-1 axis
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.